Anacetrapib T1928
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Anacetrapib (MK0859) is an effective, specific, reversible rhCETP and mutant CETP(C13S) inhibitor (IC50: 7.9 nM and 11.8 nM). Anacetrapib reduces the transfer of cholesteryl ester from HDL to LDL and/or VLDL thereby, producing an increase in serum HDL-cho
CAS nr:
875446-37-0
Purity:
98%
Molecular Weight:
637,51
SMILES:
C[C@H]1[C@H](OC(=O)N1CC2=C(C=CC(=C2)C(F)(F)F)C3=CC(=C(C=C3OC)F)C(C)C)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
Formula:
C30H25F10NO3
Pathway:
Metabolism
Target:
CETP
